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Abstract
Escherichia coli sequence type 131 (E. coli ST131) is a recently emerged and globally dis-
seminated multidrug resistant clone associated with urinary tract and bloodstream infec-
tions. Plasmids represent a major vehicle for the carriage of antibiotic resistance genes in E.
coli ST131. In this study, we determined the complete sequence and performed a compre-
hensive annotation of pEC958, an IncF plasmid from the E. coli ST131 reference strain
EC958. Plasmid pEC958 is 135.6 kb in size, harbours two replicons (RepFIA and RepFII)
and contains 12 antibiotic resistance genes (including the blaCTX-M-15 gene). We also car-
ried out hyper-saturated transposon mutagenesis and multiplexed transposon directed in-
sertion-site sequencing (TraDIS) to investigate the biology of pEC958. TraDIS data showed
that while only the RepFII replicon was required for pEC958 replication, the RepFIA replicon
contains genes essential for its partitioning. Thus, our data provides direct evidence that the
RepFIA and RepFII replicons in pEC958 cooperate to ensure their stable inheritance. The
gene encoding the antitoxin component (ccdA) of the post-segregational killing system
CcdAB was also protected from mutagenesis, demonstrating this system is active. Se-
quence comparison with a global collection of ST131 strains suggest that IncF represents
the most common type of plasmid in this clone, and underscores the need to understand its
evolution and contribution to the spread of antibiotic resistance genes in E. coli ST131.
Introduction
Escherichia coli sequence type 131 (E. coli ST131) is a recently emerged and globally disseminated
multidrug resistant clone associated with urinary tract and bloodstream infections [1, 2]. E. coli
ST131 was originally identified in 2008 as a major clone linked to the spread of the CTX-M-15 ex-
tended-spectrum β-lactamase (ESBL)-resistance gene [3–5]. Since then, E. coli ST131 has also been
strongly associated with fluoroquinolone resistance, as well as co-resistance to aminoglycosides
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and trimethoprim-sulfamethoxazole [6, 7]. Recent analyses of the global epidemiology of E. coli
ST131 using whole genome sequencing has revealed the CTX-M-15 allele is highly prevalent with-
in a fluoroquinolone resistant-FimH30 (H30) ST131 sublineage [8] and demonstrated a significant
role for recombination in the evolution of this E. coli lineage [9].
As observed for most other multidrug resistant Enterobacteriaciae pathogens, plasmids are
the major vehicles for carriage of antibiotic resistance genes in E. coli ST131. Multiple plasmids
from a range of incompatibility groups and containing various combinations of antibiotic resis-
tance genes, conjugative transfer genes and other cargo genes have been described in E. coli
ST131 strains [2]. This includes the IncF plasmids pEK499, pEK516 [10], pGUE-NDM [11],
pC15-1a [12], pJJ1886-5 [13], pEC_B24, pEC_L8, pEC_L46 [14], pJIE186-2 [15], as well as the
IncN plasmid pECN580 [16], the IncX plasmid pJIE143 [17] and the IncI plasmid pEK204
[10].
E. coli EC958 represents one of the best-characterised genome-sequenced E. coli ST131
strains [18]. E. coli EC958 is a phylogenetic group B2, CTX-M-15 positive, fluoroquinolone re-
sistant, H30 E. coli ST131 strain [19]. The strain belongs to the pulse field gel electrophoresis
defined United Kingdom (UK) epidemic strain A [20], and the recently defined ST131 Clade
C2/H30-Rx sublineage [8, 9]. E. coli EC958 contains multiple genes associated with the viru-
lence of extra-intestinal E. coli, including type 1 fimbriae which are required for adherence to
and invasion of human bladder cells, the formation of intracellular bacterial communities, and
colonization of the mouse bladder [19, 21]. In animal models, E. coli EC958 causes acute and
chronic urinary tract infection (UTI) [21] and impairment of uterine contractility [22]. E. coli
EC958 is also resistant to the bactericidal action of human serum, and the complement of
genes that define this phenotype have been comprehensively defined [23].
E. coli EC958 contains a large IncF plasmid (pEC958—HG941719) containing multiple an-
tibiotic resistance genes. Here we describe the full annotation of pEC958, and demonstrate that
genes encoded on pEC958 are common among other Clade C2/H30-Rx ST131 strains. Plasmid
pEC958 contains two replicons, and we show that both replicons contribute to its maintenance
in E. coli EC958.
Materials and Methods
Bacterial strains and growth conditions
E. coli EC958 is a UTI strain originally isolated in the UK in 2005 [19]. E. coli TOP10 has been
described previously [24]. E. coli strains were stored in 15% glycerol at -80°C and routinely cul-
tured at 37°C on solid or in liquid Lysogeny Broth (LB) medium.
Antimicrobial susceptibility testing
The minimal inhibitory concentrations (MICs) were determined by Etest (bioMérieux Austra-
lia) on Mueller-Hinton agar at 37°C. The procedure and interpretation of MIC were performed
as recommended by the manufacturer using CLSI breakpoints [25].
Molecular methods
Plasmid DNA purification was performed using the PureLink HiPure Plasmid Filter Midiprep
Kit (Life Technologies). E. coli TOP10 electro-competent cells were prepared as previously de-
scribed [23] and pEC958 plasmid DNA was transformed into TOP10 in a 2 mm cuvette using
a BioRad GenePulser set to 2.5 kV, 25 mF and 200 O. Cells were resuspended in 1 mL SOCme-
dium and incubated at 37°C for 2 hours, then selected on LB agar plates supplemented with
ampicillin 100 μg/mL.
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In silico replicon sequence typing (RST)
The FAB formula for IncF plasmids (IncF RST scheme [26]) was identified in silico using the
online pMLST tool (http://cge.cbs.dtu.dk/services/pMLST/) [27]. The pEC958 information
was uploaded to the pMLST database (http://pubmlst.org/).
Annotation of pEC958
The sequence of plasmid pEC958 (emb|HG941719) [18] was manually curated in Artemis [28]
using BLAST and literature searches. Antibiotic resistance genes were named in accordance
with ResFinder 1.4 [29] and confirmed manually by BLAST and literature searches.
TraDIS analyses
The TraDIS sequence data used in this work was generated from a previously published study
that examined essential genes in EC958 (BioProject number PRJNA189704; input A and B
samples) [23]. The short reads were mapped to the pEC958 sequence using Maq version 0.7.1
[30]. Counts of insertion per gene and insertion index were calculated as previously described
[23].
Phylogenetic tree building
The maximum-likelihood phylogenetic tree of EC958_A0140 homologs was built using the
PhyML v3.0 online tool [31]. The tree used the WAGmodel for amino acid substitution and
branch supports were calculated using approximate likelihood-ratio test (aLRT) [32].
Visualization
The read counts and insertion sites from TraDIS were visualized using Artemis version 15.0
[28]. The circular genome diagram was generated by DNAplotter [33] and linear genetic dia-
grams were constructed using Easyfig version 2.1 [34]. Circos [35] and Circoletto [36] were
used to generate the sequence comparison figure. Sequence comparisons of pEC958 against
ST131 strains were generated using BLAST Ring Image Generator (BRIG) [37].
Results
Characteristics of plasmid pEC958
The plasmid pEC958 is a 135,600 bp circular DNA molecule containing 142 coding sequences
(CDSs) and 10 pseudogenes (Fig 1). The most closely related plasmid to pEC958 is pEK499
(99% identity covering 85% of pEC958; pEK499 lacks the second transfer region present in
pEC958, which accounts for the remaining 15% of pEC958) (Fig 2). In silico replicon sequence
typing identified pEC958 as a hybrid plasmid containing both IncFII and IncFIA replicons
(FAB formula F2:A1:B-).
The RepFIA replicon
The 6,509bp RepFIA replicon in pEC958 is 99% identical to the corresponding region on the
F-plasmid (nt 45922 to 52516, accession no. NC_002483.1) and 100% identical to two other
plasmids isolated from E. coli ST131 strains, pEK499 (NC_013122.1 [10]) and pJJ1886_5
(NC_022651.1 [13]) (Fig 2). As observed in many other RepFIA sequences, this region does
not contain the repC gene (replication initiation) found on the F-plasmid. The first region of
RepFIA in pEC958 contains two rfsF sites (the target sequences of the site-specific resolvase
ResD [38]), followed by the oriV-1 origin of replication, ccdAB genes (post-segregational
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Fig 1. Circular representation of plasmid pEC958. The two outer rings show the coding sequences (CDSs) on the forward and reverse strand of the
plasmid. Each CDS is colour-coded by its predicted function as shown in the figure. The grey ring depicts mobile elements identified on the plasmid. The two
inner rings represent the GC plot and GC skew graph, respectively.
doi:10.1371/journal.pone.0122369.g001
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killing), and resD (multimer resolution). The second region of RepFIA in pEC958 contains the
replication repE gene (RepFIA) with its upstream sequences ssiA (single strand initiation) and
oriV-2 (including the DnaA boxes, A/T rich region and four iterons), and the downstream
incC iterons (incompatibility and copy-number control). The third region of RepFIA in
pEC958 contains the sopAB partition genes and their target centromere-like sopC sequence.
Fig 2. Sequence comparison of pEC958 with other closely related plasmids.Regions on plasmids are colour-coded as followed: red—replicon, blue—
conjugation transfer, orange—mobile elements, dark pink—antimicrobial resistance genes.
doi:10.1371/journal.pone.0122369.g002
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This is the only partition system found on pEC958. Although this RepFIA replicon contains
two origins of replication (oriV-1 and oriV-2), replication is predicted to start unidirectionally
from oriV-2 because the bidirectional replication from oriV-1 is known to require the missing
RepC protein [39, 40].
The RepFII replicon
The second replicon in pEC958, RepFII (4,068 bp), is 99% identical to the IncFII replicon in
the Shigella flexneri 2b plasmid R100 (accession no. NC_002134.1, [41]) and 100% identical to
the RepFII replicon in the E. coli ST131 plasmid pEK499 (Fig 1). This replicon encodes the es-
sential gene for its replication, repA1, which is regulated by the negative regulator RepA2
(CopB), the non-coding RNA copA and the regulatory leading peptide RepA6 [42–44]. The
pEC958 RepFII origin of replication (ori) is located between repA1 and repA4, consistent with
previous descriptions for the initiation of DNA replication from this replicon [42, 45–47]. The
repA4 region is important for plasmid stability and contains the ter sites for replication termi-
nation [48]. The pEC958 RepII replicon contains the tir (transfer inhibition protein [49]) and
the type II toxin-antitoxin system pemI/pemK [50, 51] downstream of repA4.
The transfer region of pEC958 is not functional
The transfer (tra) region of pEC958 is disrupted by a composite mobile element flanked by
IS26a and IS26b, carrying blaTEM-1 gene (Fig 1). The first half of this tra region is 100% identi-
cal to the corresponding region on pEK499 (F2:A1:B-), and 99% identical to the corresponding
region of several other IncF plasmids including pJJ1886_5 (F2:A1:B-), pEC_L46 (F2:A1:B-),
pEC_L8 (F2:A1:B-), pEFC36a (F2:A-:B-) and pChi7122-2 (F11:A-:B-). In contrast, the second
half of the pEC958 tra region is 100% identical to pC15-1a (F2:A-:B-), R100 (F2:A-:B-),
pHN3A11 (F2:A-:B-), pFOS-HK151325 (F2:A-:B-), pXZ (F2:A-:B-), pHK23a (F2:A-:B-),
pHK01 (F2:A-:B-) and pEG356 (F2:A-:B-). However, the pEC958 conjugation system is miss-
ing three genes, namely trbI, traW and traU. TrbI is an inner membrane protein that affects
pilus retraction [52]; TraW is required for F-pilus assembly [52]; and mutations in traU signifi-
cantly reduce plasmid transfer proficiency [53]. Despite repeated attempts, we were unable to
demonstrate conjugative transfer of pEC958 to recipient strains, supporting the bioinformatic
prediction that its conjugation system is non-functional (data not shown).
Toxin-antitoxin systems
The pEC958 plasmid encodes four toxin-antitoxin (TA) systems: the hok/sok system, the
ccdAB system encoded within RepFIA, the pemIK system encoded within RepFII and the
vagDC system. The hok/sok locus encodes a type I TA system including a “host killing” (hok)
transmembrane protein that damages the cell membrane, a “modulation of killing” (mok) and
a “suppression of killing” (sok) antisense RNA that inhibits translation ofmok [54]. Both
ccdAB and pemIK belong to type II TA system where the toxin protein is inactivated by direct
interaction with the antitoxin protein. The ccdB gene encodes for a gyrase inhibitor toxin [55]
that kills the cell in the absence of the CcdA anti-toxin, which is unstable and degraded by the
Lon protease [56]. PemK is a sequence-specific endoribonuclease that cleaves mRNAs to inhib-
it protein synthesis [50] whereas PemI blocks the endoribonuclease activity and is also sub-
jected to Lon proteolysis [57].
There are two identical copies of the vagDC genes in pEC958. Sequence analysis of VagD re-
vealed a PIN_VapC-FitB (cd09881) domain found in toxins of many bacterial TA systems.
VagC contains an antitoxin-MazE (pfam04014) domain. The vagDC genes have been shown to
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be involved in plasmid stability in Salmonella Dublin, where VagD inhibits cell division and
VagC modulates the activity of VagD [58].
Mobile genetic elements and antibiotic resistance genes
The majority of mobile genetic elements and antibiotic resistant genes in pEC958 cluster in
two regions: an 8-kb region in the middle of the tra region, and a 41-kb region located immedi-
ately downstream of the RepFII replicon (Fig 1). Plasmid pEC958 contains eight IS26 elements
(named IS26a-IS26h), two IS1 elements, one ISEc23 element and one group II intron (E.c.I11,
found outside of the two regions) (Fig 3). IS26a and IS26b are located at the two ends of the
8-kb region, flanking ISEcp1, a remnant of Tn3, which includes the blaTEM-1 gene, and a partial
sequence of Tn21. The beginning of the 41-kb region contains a partial sequence of Tn5403 fol-
lowed by IS26c. The region between IS26c and IS26d contains a cluster of 6 genes
(EC958_A0096 to EC958_A0101) predicted to encode a series of ABC transporters and an iron
permease. Downstream of IS26d is a class I integron In54 [59] with gene cassettes consisting of
dfrA17, aadA5 and sulI, encoding trimethoprim, streptomycin and sulfonamide resistance, re-
spectively. ThemphR-mrx-mph(A) operon encoding resistance to macrolides is located be-
tween IS6100 and IS26e. Immediately after IS26e is the blaCTX-M-15 gene encoding cefotaxime
resistance. Located between IS26f and IS26g are catB4Δ (non-functional; disrupted by IS26f),
blaOXA-1 (beta-lactam resistance) and aac(6’)-Ib-cr (fluoroquinolone and aminoglycoside resis-
tance). After IS26g lies Tn1721, which harbours tetR and tet(A), encoding resistance to tetracy-
cline. The end of the 41-kb region contains a partial sequence of Tn5403 and IS26h.
Functional characterization of antibiotic resistance genes on pEC958
To investigate the antibiotic resistance phenotypes conferred by plasmid pEC958, we trans-
formed the plasmid into E. coli TOP10. Table 1 shows the resistance profile of wild-type EC958
(which contains pEC958) compared to TOP10(pEC958). EC958 is resistant to 11 of the 18 an-
tibiotics tested, five of which are fully transferable via pEC958. EC958 is resistant to the cepha-
mycin cefoxitin and the three third-generation cephalosporins tested (cefotaxime, ceftazidime
and cefpodoxime). These phenotypes, however, were not fully transferred to TOP10 by
pEC958. TOP10(pEC958) had elevated MICs to cefoxitin, cefotaxime, ceftazidime and cefpo-
doxime (MIC of 6, 1.5, 1.5 and 8.0 μg/mL, respectively) compared to the background strain
TOP10 (MIC of 4, 0.047, 0.38 and 0.25 μg/mL, respectively), but these MICs were still 6–10
fold lower than those of the EC958 wild-type strain. This suggests that blaCTX-M-15 on pEC958
plasmid does not mediate the full resistance against third-generation cephalosporins. This is
Fig 3. Organizational structure of mobile elements and antibiotic resistance genes on plasmid pEC958. The colour coding is as followed: red—IS26
(8 copies IS26a to IS26h), yellow—ISEcp1, brown—Tn3 (partial), sky blue—Tn21 (partial), light green—IS1, dark pink—Tn5403, green—IS6100, dark blue
—Tn1721, orange—ISEc23, dark pink—In54. Target duplication sites are indicated by triangle flags. The white blocks represent large regions not detailed in
this figure.
doi:10.1371/journal.pone.0122369.g003
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consistent with previous reports of lower resistance to cephalosporins in strains where the
blaCTX-M-15 is separated by IS26 from its promoter within the ISEcp1 element [60–63]. The
other resistance phenotypes not transferred were for quinolones and fluoroquinolones. Chro-
mosomal mutations in gyrA (S83L, D87N, A828S) and parC (S80I, E84V, A192V, A471G,
D475E, Q481H) genes are likely to mediate these phenotypes, even though the plasmid carries
aac(6’)-Ib-cr [64–66].
Genes required for the stable maintenance of pEC958
In order to gain insights into molecular mechanisms of plasmid stability, we analyzed the Tra-
DIS data from a saturated transposon mutant library of EC958 [23] against the complete se-
quence of pEC958 to identify genes required for plasmid stability. We used a total of 12 million
transposon-tagged reads, of which 901,588 reads (7.4%) were mapped to plasmid pEC958,
identifying 27,317 unique insertion sites (i.e. one insertion site every 4.96 bp). To devise a bio-
logical threshold for the identification of genes required for the stable maintenance of pEC958,
the insertion index (number of mapped reads normalized by gene length) of each plasmid gene
was calculated and compared with the sopAB genes, which are known to be essential for plas-
mid partitioning (Fig 4).
A total of 9 genetic elements were identified to be required for the stable maintenance of
pEC958. They are the ccdA, sopA and sopB genes in RepFIA; the copA, repA6, repA1, repA4
genes and the oriV region in RepFII; and the hypothetical gene EC958_A0140. Our results in-
dicate that replication of pEC958 is initiated at the oriV of RepFII and requires at least the
copA, repA6, repA1, repA4 genes. While RepFIA is not essential for replication, it is required
for partitioning (sopAB) of pEC958 into daughter cells. Our data also demonstrated that the
ccdAB TA system located within RepFIA is functional.
Table 1. Antibiotic resistance profiles (MIC, μg/mL) of EC958 and its pEC958 transformant in E. coli TOP10.
Antibiotics Strains
EC958 TOP10 TOP10 + pEC958
Ampicillin 256 (R) 2 (S) 256 (R)
Amoxicillin/Clavulanic Acid 24 (R) 3 (S) 16 (R)
Aztreonam 2 (S) 0.094 (S) 1 (S)
Cefoxitin 48 (R) 4 (S) 6 (S)
Cefotaxime 12 (R) 0.047 (S) 1.5 (I)
Ceftazidime 16 (R) 0.38 (S) 1.5 (S)
Cefpodoxime 48 (R) 0.25 (R) 8.0 (R)
Imipenem 0.25 (S) 0.19 (S) 0.25 (S)
Meropenem 0.125 (S) 0.064 (S) 0.094 (S)
Nalidixic Acid 256 (R) 0.38 (S) 0.50 (S)
Ciproﬂoxacin 32 (R) 0.003 (S) 0.008 (S)
Sulfamethoxazole/Trimethoprim 32 (R) 0.032 (S) 32 (R)
Kanamycin 256 (R) 2 (S) 256 (R)
Amikacin 24 (I) 3 (S) 24 (I)
Tetracycline 256 (R) 0.5 (S) 192 (R)
Tigecycline 0.38 (S) 0.094 (S) 0.38 (S)
Fosfomycin 0.5 (S) 0.38 (S) 0.38 (S)
Nitrofurantoin 4 (S) 0.094 (S) 0.094 (S)
doi:10.1371/journal.pone.0122369.t001
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EC958_A0140 represents a novel gene associated with plasmid maintenance. We screened
the NCBI complete plasmid sequence database and identified 17 other plasmids that also con-
tain this gene (Fig 5). All of these plasmids were IncF type except for pECL_A (non-typable),
and several were also isolated from E. coli ST131 strains (pJJ1886_5, pEK499, pEC_L8 and
pEC_L46). Bioinformatic analysis of EC958_A0140 did not yield any clues regarding is func-
tion, and thus further work is required to confirm its role in plasmid stability.
pEC958-like plasmid sequences are highly prevalent in ST131
The prevalence of pEC958-like plasmid sequences was assessed in a previously described global
collection of 97 E. coli ST131 strains [9]. Fig 6 shows the overview of plasmid sequences from
97 ST131 strains plus four complete ST131 plasmids available on GenBank in comparison with
the pEC958 sequence. There are 20 strains and 2 database plasmids (pEK499 and pJJ1886_5)
that contain more than 70% of pEC958 gene content, all of which belong to the clade C subli-
neage C2 (40%) (Fig 6 and S1 Table). Twelve out of these 20 strains (plus pEK499) also harbor
all 9 pEC958 essential genes identified above.
In silico replicon sequence typing of IncF plasmids was also performed on the 97 strains.
Table 2 shows the 8 most common FAB types found within this collection. The FAB formula
of pEC958, F2:A1:B-, is also the most common replicon type, accounting for 20.6% of all 97 E.
coli ST131 strains, or 27.8% of clade C strains, all of which also belong to subclade C2. The sec-
ond most common type is F1:A2:B20, of which 17 are in subclade C1 and 1 is in clade A. In
Fig 4. Overview of the TraDIS screen for the identification of pEC958 essential genes. (A) Graph showing the insertion index of each gene on pEC958
(top) in relation to the overall genetic organization of the plasmid (bottom). Nine essential genes (indicated in red) were identified that possessed an insertion
index lower than 0.05. (B, C, D) Schematic showing the frequency of Tn insertions mapping to specific regions of pEC958. Essential genes required for the
stable maintenance of pEC958 possessed a significantly reduced number of insertions.
doi:10.1371/journal.pone.0122369.g004
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terms of individual replicons, FIB is present in 100% of clade A and B strains, while FII is most
common in clade C (87.5%; S1 Table). Based on our sequence analysis, 3/97 strains do not har-
bor an IncF plasmid.
Discussion
Our study presents a full annotation of pEC958, a multi-drug resistance plasmid in the well-
characterized E. coli ST131 strain EC958 [18, 19, 23]. In addition, we identified genes required
for the maintenance and stability of pEC958. Although IncF plasmids are extremely successful
in the E. coli ST131 clonal lineage [67], this is the first study to examine the biology of an IncF
plasmid in its native host using TraDIS [68]. The replication and stability of IncF plasmids (F-
plasmid, R1, and R100) has been well documented [39, 47, 69, 70]. Here we provide insights
into the interplay between two replicons in order to achieve stable maintenance of the circular
plasmid DNA on which they co-exist.
The data analysis in this study used a straight cut-off based on the insertion index of the
sopAB genes, which encode the partitioning system of pEC958. Mutation of sopAB is known to
cause destabilization of IncF plasmids and thus they represent characterised genes involved in
plasmid stability [71, 72]. This deviation from the model-based approach, in which the cut-off
is defined as the intercept of two distribution models representing essential and non-essential
genes [23], was chosen because of two reasons: (i) the number of genes on plasmid is insuffi-
cient to build two distribution models; and (ii) the cut-off previously defined using chromo-
somal data is not applicable because of the higher insertion frequency on the plasmid (i.e. one
insertion every 4.96 bp compared to every 9.92 bp on the chromosome). In the case of the well-
characterised IncF system, use of a straight cut-off assumed that any gene with an insertion
index lower than the sopAB genes would have a similar or stronger effect on plasmid stability.
The stable maintenance of large plasmids such as pEC958 is achieved by the contribution of
multiple factors, including systems involved in replication, partitioning and toxin-antitoxin
production. Using the strategy outlined, we aimed to identify genes that when mutated caused
destabilization of plasmid pEC958—thus they must play a role in plasmid stability.
Fig 5. Maximum-likelihood phylogenetic tree showing the relationship of EC958_A0140 translated amino acid sequences. EC958_A0140
sequenced are labeled by plasmid name. Also shown is the replicon nomenclature for each plasmid according to the FAB scheme and the parent organism.
doi:10.1371/journal.pone.0122369.g005
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Fig 6. BRIG image depicting the presence of pEC958-like sequences in E. coli ST131 strains. The strains are coloured according to their previously
defined phylogenetic relationship: red (Clade A), orange (Clade B) and green (Clade C) [9]. The degree of coloured shading indicates the level of identity
according to BLASTn between pEC958 (nucleotide position highlighted on the inner circle) and the draft Illumina assemblies of the E. coli ST131 strains [9].
BLASTn matches are coloured based on a nucleotide identity of between 70% and 90% (dark shading = high identity, light shading = low identity). Blank
spaces in each ring represent BLASTn matches to pEC958 with less than 70% nucleotide identity, or pEC958 regions with no BLAST matches. Four strains
originally characterised as ST131 but later shown to be ST95 are shown in black. Highlighted on the outer ring are the RepFII and RepFIA replicons, as well
as antibiotic resistance genes, transposons and IS elements.
doi:10.1371/journal.pone.0122369.g006
Molecular Characterization of an E. coli ST131 IncF Plasmid
PLOS ONE | DOI:10.1371/journal.pone.0122369 April 15, 2015 11 / 17
Our results showed that RepFII, particularly the copA, repA1, repA4 genes and oriV region,
is required for the replication of pEC958. This is consistent with previous studies on the func-
tion of RepFII in the IncFII plasmid R100 [41]. In contrast to R100, the RepFII region on
pEC958 does not contain its own intrinsic partition system (stb locus on R100 [73, 74]). Fur-
thermore, we could not identify any region that resembles a partition site (centromere-like)
elsewhere on pEC958 other than within the RepFIA region. Thus, it is reasonable to assume
that the sopAB genes in the RepFIA region [75, 76] represent the only active partition system
on pEC958. Indeed, our transposon mutagenesis revealed a very low insertion index for both
sopA and sopB, confirming the requirement of these two genes for pEC958 partitioning and al-
lowing us to use these genes as a reference threshold to identify biologically significant genes
required for plasmid maintenance.
Using TraDIS, we were able to demonstrate that none of the known replication genes in
RepFIA are required for pEC958 replication. This included the oriV-1 of RepFIA, which was
not expected to be functional due to the absence of the repC gene [40]. The oriV-2 and its asso-
ciated genes in RepFIA appear to be intact yet dispensable in pEC958. Similar behavior has
been reported in the dual-replicon plasmid pCG86, which contains an active RepFII replicon
and an inactive (but intact) RepFIB replicon [77]. This is consistent with a previously proposed
model for plasmid speciation, in which the existence of co-integrate plasmids (such as
pEC958) allows one replicon to be relaxed and free to accumulate mutations whilst the other
replicon is constrained by evolutionary pressure to maintain its replication function [78].
The RepFIA also carries one toxin-antitoxin system ccdAB in which the antitoxin CcdA is
protected from transposon mutagenesis, indicating that the system is active in pEC958. There
are three other TA systems in pEC958, none of which were required for plasmid stability under
the conditions tested in this study. Others have suggested that TA systems are more than just
plasmid maintenance systems; they can also function as a stress-response system [79, 80], as a
programmed cell-death network [81], or as a reversible bacteriostasis system (i.e. induction of
dormancy or persistence) [82, 83]. It is conceivable that the redundancy of TA systems on
pEC958 is linked to other functions that provide a fitness advantage to its host.
Plasmids of several different incompatibility types have been identified in E. coli ST131, in-
cluding IncF, IncI1, IncN, IncA/C and pir-type [2]. Our data demonstrates that IncF plasmids
Table 2. Prevalence of IncF plasmid types in E. coli ST131 strains.
FAB formulaa E. coli ST131 Total
Clade A (n = 9) Clade B (n = 16) Clade C (n = 72) (n = 97) %
F2:A1:B- 20 20 20.6
F1:A2:B20 1 17 18 18.6
F-:A-:B10 2 7 9 9.3
F22:A1:B20 6 6 6.2
F36:A-:B1 5 5 5.2
F2:A-:B1 4 4 4.1
F48:A1:B26 4 4 4.1
F2:A-:B- 3 3 3.1
Othersb 5 5 15 25 25.8
Not IncF 1 2 3 3.1
a We used FAB formula to indicate FII, FIA and FIB alleles found in each strain. It does not imply that these alleles are located on the same circular
plasmid DNA molecule.
b There are 27 unique FAB types found in 97 strains. Eight most prevalence types are presented here, the remaining are provided in S1 Table.
doi:10.1371/journal.pone.0122369.t002
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are the most common plasmid type in E. coli ST131, and is in accordance with previous studies
[2, 4]. To investigate the prevalence of pEC958 sequences in our strain collection, we used ge-
nome sequence data to evaluate the prevalence of pEC958 genes and to perform in silico IncF
replicon sequence typing. We identified 20 strains (including EC958) that contained more
than 70% of the genes identified on pEC958, suggesting that many ST131 strains carry very
similar plasmids. We also identified 20 strains that possess the F2:A1:B- plasmid replicon for-
mula, 17 of which contain>70% of pEC958 genes. Taken together, our data demonstrate that
pEC958 belongs to the most common group of IncF plasmids found in E. coli ST131.
The overall success of IncFII plasmids extends beyond the carriage of blaCTX-M-15 in E. coli
ST131. IncFII plasmids that have acquired the blaNDM-1 gene (thus conferring carbapenem re-
sistance) have been described in the ST131 lineage [11, 84], but strain EC958 was isolated prior
to the discovery of NDM determinants and we did not find any NDM determinants in the 97
ST131 strain collection. The IncFIIk plasmid, a replicon type originally found in Klebsiella [26],
has also been found in KPC-producing ST131 strains in the USA and China [85, 86]. The evo-
lution and continual gain of new antimicrobial resistance determinants in IncFII plasmids rep-
resents a major challenge for our understanding of plasmid biology and the spread of antibiotic
resistance genes. Here, we shed novel insight into our knowledge of plasmid replication by pro-
viding direct evidence that the RepFIA and RepFII replicons in pEC958 cooperate to ensure
their stable inheritance. The combination of replication from RepFII and partition from
RepFIA may represent a co-evolutionary adaptation for this common plasmid type.
Supporting Information
S1 Table. The presence/absence of pEC958 coding sequences in E. coli ST131 strains.
(XLSX)
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